Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 65 for “"Utrophin"”.

  1. The utrophin-actin interface

    … of the individual proteins differ greatly. Utrophin is a member of the spectrin superfamily and has been used extensively to investigate and model the association of actin-binding domains with F- actin; however, much controversy exists as to whether binding occurs when the domain is in an …

    glasgow Download PDF for The utrophin-actin interface (opens in a new tab)

  2. Biophysical and functional consequences of sequence changes on dystrophin and utrophin

    … or disruption of key ligand binding domains. Utrophin has a highly similar overall structure to dystrophin and is part of the homologous utrophin-glycoprotein complex (UGC) present during fetal development and is localized to neuromuscular and myotendinous junctions in adult muscle. Our lab …

    umn Repository record for Biophysical and functional consequences of sequence changes on dystrophin and utrophin (opens in a new tab)

  3. Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research

    … therapeutic options to combat this disease. Utrophin is a paralogue of dystrophin. The Fiona mouse is an mdx (dystrophin-deficient) transgenic mouse that overexpresses the full-length utrophin protein in skeletal muscle, and various studies have shown that it does not display a dystrophic …

    oxford Repository record for Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research (opens in a new tab)

  4. A biochemical and molecular analysis of functional differences between dystrophin and utrophin

    … aim at upregulating its autosomal homolog utrophin due to its structural similarity and ability to bind an almost identical repertoire of proteins that dystrophin binds. It was previously shown that utrophin cannot bind neuronal nitric oxide synthase (nNOS) even though dystrophin binds …

    umn Repository record for A biochemical and molecular analysis of functional differences between dystrophin and utrophin (opens in a new tab)

  5. Skeletal Muscle Specific IRES Activity of Utrophin A Is Enhanced by Eef1a2

    … the regulatory mechanisms controlling utrophin A expression at the sarcolemma of dystrophic muscles will facilitate the development of therapeutic strategies to ameliorate the pathophysiological features of Duchenne Muscular Dystrophy (DMD). The main goal of this study was to …

    ottawa-retro Repository record for Skeletal Muscle Specific IRES Activity of Utrophin A Is Enhanced by Eef1a2 (opens in a new tab)

  6. Molecular mechanisms contributing to the expression of utrophin at the mammalian neuromuscular synapse.

    … distribution of dystrophin along muscle fibers, utrophin preferentially accumulates at the neuromuscular junction. Due to this sequence similarity between dystrophin and utrophin, it has been suggested that increased expression of utrophin into extrasynaptic regions of dystrophic muscle fibers …

    ottawa-retro Repository record for Molecular mechanisms contributing to the expression of utrophin at the mammalian neuromuscular synapse. (opens in a new tab)

  7. Utrophin A Upregulation by FDA-Approved Drugs for the Treatment of Duchenne Muscular Dystrophy

    … consists of upregulating the endogenous protein utrophin A in dystrophic muscle, which, once highly expressed at the sarcolemma, could functionally compensate for the lack of dystrophin. Recent evidence demonstrates that utrophin A expression is regulated at its 3’ and 5’UTR through …

    ottawa-retro Repository record for Utrophin A Upregulation by FDA-Approved Drugs for the Treatment of Duchenne Muscular Dystrophy (opens in a new tab)

  8. Combinatorial Utrophin A Activation in Muscle as a Therapeutic Strategy to Treat Duchenne Muscular Dystrophy

    … mutations or deletions in the dystrophin gene. Utrophin up-regulation therapy is among the various therapeutic strategies that are being investigated to treat DMD. In this strategy utrophin, a dystrophin homologue, is up-regulated along the entire length of the sarcolemma to replace the absent …

    ottawa-retro Repository record for Combinatorial Utrophin A Activation in Muscle as a Therapeutic Strategy to Treat Duchenne Muscular Dystrophy (opens in a new tab)

  9. Mechanism of action studies of the utrophin modulator ezutromid for the treatment of Duchenne muscular dystrophy

    … One such therapy aims to promote expression of utrophin, an autosomal paralogue of dystrophin. Utrophin upregulation rescues the dystrophic phenotype in disease model mice. A novel small molecule utrophin modulator, ezutromid (Summit Therapeutics; formerly SMT C1100), which was identified using …

    oxford Repository record for Mechanism of action studies of the utrophin modulator ezutromid for the treatment of Duchenne muscular dystrophy (opens in a new tab)

  10. Molecular interactions of the intermediate filament protein synemin with both dystrophin and utrophin in muscle cells

    … the sarcolemma of normal skeletal muscle cells. Utrophin is present primarily at the sarcolemma in the neuromuscular and myotendinous junctions (NMJs and MTJs) in normal skeletal muscle cells. Dystrophin and its paralogue, utrophin, belong to the spectrin family of proteins, which include …

    iastate Repository record for Molecular interactions of the intermediate filament protein synemin with both dystrophin and utrophin in muscle cells (opens in a new tab)

  11. Molecular mechanisms affecting utrophin expression in fast versus slow skeletal muscles; possible therapeutic targets for Duchenne muscular dystrophy

    … protein that can compensate for dystrophin. Utrophin is one such protein, primarily expressed at the neuromuscular junction, which can compensate for dystrophin function. Therefore, it becomes imperative to identify pathways that regulate the expression of utrophin. Such efforts could …

    ottawa-retro Repository record for Molecular mechanisms affecting utrophin expression in fast versus slow skeletal muscles; possible therapeutic targets for Duchenne muscular dystrophy (opens in a new tab)

  12. Targeting transcriptional and translational mechanisms to enhance utrophin A expression as a therapy for Duchenne muscular dystrophy

    … integrity and progressive muscle wasting. Utrophin is the autosomal homologue of dystrophin and is present in skeletal muscles of DMD patients, although its expression is primarily restricted to the neuromuscular junction of mature skeletal muscle fibers. Enhancing expression of utrophin in …

    ottawa-retro Repository record for Targeting transcriptional and translational mechanisms to enhance utrophin A expression as a therapy for Duchenne muscular dystrophy (opens in a new tab)

  13. Towards the elucidation of the mechanism of action of small molecule upregulators of utrophin using chemical proteomics

    … by replacing it with its autosomal paralogue utrophin. This therapy will be applicable to all patients regardless of their dystrophin mutation and will target skeletal muscle, heart and diaphragm. In partnership with Summit Therapeutics, ezutromid (SMT C1100), a small molecule utrophin …

    oxford Repository record for Towards the elucidation of the mechanism of action of small molecule upregulators of utrophin using chemical proteomics (opens in a new tab)

  14. The role of the 5'-untranslated region in regulating the expression of utrophin in skeletal muscle cells

    Up-regulating utrophin expression at the sarcolemma is thought to be a key therapeutic approach in the fight against DMD. Utrophin was found to have two isoforms which differ mainly in their 5'-untranslated regions. Effects of the utrophin 5'UTRs on reportergene expression in cell culture and …

    ottawa-retro Repository record for The role of the 5'-untranslated region in regulating the expression of utrophin in skeletal muscle cells (opens in a new tab)

  15. Investigating the Potential Effectiveness of Two Therapeutic Targets, Utrophin and HSP70, in the Treatment of Duchenne Muscular Dystrophy

    … the proper functioning of skeletal muscle. Both utrophin and HSP70 have been suggested to have potential therapeutic potential as a result of their preferential expression in the relatively damage-resistant slow, oxidative fibres. In my studies, I found that by forcing transgenic expression of …

    concordia Download PDF for Investigating the Potential Effectiveness of Two Therapeutic Targets, Utrophin and HSP70, in the Treatment of Duchenne Muscular Dystrophy (opens in a new tab)

  16. Role of Utrophin, Sarcospan, and Glycosyltransferase Activity in the Pathogenesis of Duchenne Muscular Dystrophy and a Representative Case Study

    … The interactions of the proteins sarcospan and utrophin as well as related glycosyltransferase activity are further examined in depth. A case study of a 5 year old patient is discussed in order to shed light on the clinical manifestations of the disease in its early stages.

    unr Repository record for Role of Utrophin, Sarcospan, and Glycosyltransferase Activity in the Pathogenesis of Duchenne Muscular Dystrophy and a Representative Case Study (opens in a new tab)

  17. Determining the Contribution of Utrophin A Versus Other Components of the Slow, Oxidative Phenotype in the Beneficial Adaptations of Dystrophic Muscle Fibers Following AMPK Activation

    … upregulation of dystrophin’s autosomal analogue, utrophin A. This can be achieved by a pharmacologically induced shift towards a slower, more oxidative skeletal muscle phenotype, which has been shown to confer morphological and functional improvements on models of DMD. Whether these improvements …

    ottawa-retro Repository record for Determining the Contribution of Utrophin A Versus Other Components of the Slow, Oxidative Phenotype in the Beneficial Adaptations of Dystrophic Muscle Fibers Following AMPK Activation (opens in a new tab)

  18. Conformational changes in actinin-type actin binding domains: probing actin-induced structural dynamics in dystrophin and utrophin using EPR spectroscopy.

    … Dystrophin, and its autosomal homologue utrophin, connect with the actin cytoskeleton through two F-actin binding domains, including an N-terminal "actinin-type" actin binding domain (ABD).In addition to dystrophin and utrophin, actinin-type ABDs are found in a large number of proteins. …

    umn Repository record for Conformational changes in actinin-type actin binding domains: probing actin-induced structural dynamics in dystrophin and utrophin using EPR spectroscopy. (opens in a new tab)

Page 1 of 4